REPURGENESIS CO., LTD.
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
Integrated AI Drug Discovery Platform: An AI-driven multi-model platform that accelerates drug repurposing by integrating diverse data types, multiple R&D methodologies, various analytical modalities, and a wide range of AI algorithms.
Founded Year
2025
Unified Business No.
60593116
Status
Active
Number of Employees
0
Total Paid-in
Capital
95,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
REPURGENESIS is an AI-driven biotechnology company that has pioneered the “Intelligent Orchestrating” paradigm. By coordinating multiple models, diverse datasets, and multimodal mechanisms, it comprehensively accelerates the end-to-end drug repurposing process. Through an AI-orchestrated ecosystem, REPURGENESIS integrates molecular structure modeling, omics analysis, knowledge graph reasoning, and clinical evidence mining to uncover new therapeutic potential in existing drugs—seamlessly bridging computational discovery and experimental validation within a continuous and intelligent cycle.
